Japan, May 18 -- SELECTA BIOSCIENCES INC has got intellectual property rights for 'METHOD AND COMPOSITION FOR ENHANCING CD4+ REGULATORY T CELL.' Other related details are as follows:

Application Number: JP,2022-197386

Category (FI): A61K38/19,A61K38/18,A61K38/00,A61K31/7088,A61K31/436,A61K47/34,C12N9/00,C07K16/18,C07K14/745,C07K14/52,A61P43/00,121,A61P43/00,111,A61P37/06,A61K9/14,A61K9/127,A61K9/107,A61K48/00,A61K47/69,A61K47/62,A61K47/60,A61K47/59,A61K47/56,A61K45/06,A61K39/395@N,A61K39/395@D,A61K38/53,A61K38/52,A61K38/51,A61K38/46,A61K38/45,A61K38/44,A61K38/43,A61K38/37,A61K38/36,A61K38/22,A61K38/21

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Dec. 9, 2022

Publication Date: March 22, 2023

The origi...